| Literature DB >> 35564348 |
Alvisa Palese1, Maddalena Peghin2, Valentina Bressan1, Margherita Venturini1, Valentina Gerussi2, Giulia Bontempo2, Elena Graziano2, Erica Visintini1, Carlo Tascini2.
Abstract
The COVID-19 pandemic emotionally affected the lives of patients cared for in different settings. However, a comprehensive view of the whole experience as lived by survived patients, from the onset of the disease and over time, is substantially unknown to date. A descriptive qualitative design was implemented according to the Standards for Reporting Qualitative Research. Adult patients (=1067) cared for during the first wave (March/April 2020) capable of answering an interview and willing to participate were interviewed (=397) by phone with an interview guide including open- and closed-ended questions. In this context, they were asked to summarise with a metaphor their entire COVID-19 experience at six months. Then, the emotional orientation (positive, neutral, or negative) of the metaphors expressed was identified. The participants were mainly female (206; 51.9%), with an average age of 52.6 years (CI 95% 50.4-53.6), reporting a mild severity of COVID-19 disease at the onset (261; 65.7%) and the perception of being completely healed (294; 70%) at six months. The patients summarised their experiences mainly using negative-oriented (248; 62.5%) metaphors; only 54 (13.6%) reported positive-oriented metaphors and a quarter (95; 23.95) neutral-oriented metaphors. Nearly all positive-oriented metaphors were reported by patients with symptoms at the onset (53; 98.1%), a significantly higher proportion compared to those reporting negative- (219; 88.3%) and neutral-oriented (78; 82.1%) metaphors (p = 0.014). While no other clinical features of the disease were associated, among females, significantly more negative-oriented metaphors emerged. Moreover, neutral-oriented metaphors were reported by younger patients (49.5 years, CI 95% 64.11-52.92) as compared to those negative and positive that were reported by more mature patients (53.9; CI 95% 52.04-55.93 and 54.8; CI 95% 50.53-59.24, respectively) (p = 0.044). Nurses and healthcare services require data to predict the long-term needs of patients. Our findings suggest that, for many patients, the COVID-19 lived experience was negative over time.Entities:
Keywords: COVID-19; Coronavirus Disease 19; follow-up; lived experience; metaphors; qualitative study
Mesh:
Year: 2022 PMID: 35564348 PMCID: PMC9106002 DOI: 10.3390/ijerph19094954
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Flow chart showing patients diagnosed with COVID-19 interviewed six months after the onset. Legend. COVID-19, Coronavirus Disease 19.
Characteristics of the interviewed patients.
| At the COVID-19 Onset | |
|---|---|
| Gender | |
| Female | 206 (51.9) |
| Male | 191 (48.1) |
| Age (years), mean (CI 95%) | 52.6 (50.4–53.6) |
| Nationality | |
| Italian | 366 (92.2) |
| Non-Italian | 31 (7.8) |
| Education | |
| None | 1 (0.3) |
| Primary School | 22 (5.5) |
| Middle School | 65 (16.4) |
| High School | 160 (40.3) |
| Bachelor’s Degree | 83 (20.9) |
| Ph.D. | 3 (0.8) |
| Missing | 63 (15.9) |
| COVID-19 severity, WHO scale [ | |
| Asymptomatic | 51 (12.8) |
| Mild disease (without pneumonia) | 261 (65.7) |
| Moderate disease (pneumonia) | 60 (15.1) |
| Severe disease (severe pneumonia) | 13 (3.3) |
| Critical disease, including acute respiratory distress syndrome (ARDS), sepsis and/or septic shock | 9 (2.2) |
| Missing | 3 (0.8) |
| Hospitalised for COVID-19 | |
| Yes | 101 (25.4) |
| Department(s)/units § | |
| Infectious Disease | 83 (82.2) |
| COVID-19 | 17 (16.8) |
| Intensive Care | 14 (13.9) |
| Pneumology | 11 (10.9) |
| Hospitalisation (days), mean (CI 95%) | 10.1 (8.0–12.3) |
| Previous comorbidities | |
| Yes | 207 (52.1) |
| Infected by whom | |
| I don’t know | 128 (32.2) |
| Family members | 229 (57.7) |
| Colleagues | 32 (8.1) |
| Family members and colleagues | 8 (2.0) |
| COVID-19 symptoms at the COVID-19 onset | |
| Yes | 350 (88.2) |
| No | 47 (11.8) |
| Symptoms, number, mean (CI 95%) | 4.75 (4.51–5.0) |
| Among symptoms, dyspnoea | 114 (32.6) |
| At six months after the COVID-19 onset | |
| Feeling completely healed | |
| Yes | 294 (70.0) |
| No | 88 (22.2) |
| Uncertain | 15 (3.8) |
| Persisting COVID-19 symptoms | |
| Yes | 128 (32.2) |
| No | 250 (63.0) |
| Uncertain | 19 (4.8) |
Legend: CI, confidence interval; COVID-19, Coronavirus Disease 19; N, number; Ph.D., Doctor of Philosophy; SD, standard deviation; WHO, World Health Organization: asymptomatic; mild disease (without pneumonia); moderate disease (pneumonia); severe disease (severe pneumonia); critical disease, including acute respiratory distress syndrome (ARDS), sepsis, and/or septic shock [27]. § Some patients were hospitalised in more than one department.
‘My lived experience as a COVID-19 survived patient’: metaphors and their orientation (=397).
| Negative-Oriented | Neutral-Oriented | Positive-Oriented |
|---|---|---|
|
|
|
|
Legend: COVID-19, Coronavirus Disease 19.
Metaphors’ orientations, according to the patients’ characteristics and over time.
| At the COVID-19 Onset | Negative-Oriented | Neutral-Oriented | Positive-Oriented | |
|---|---|---|---|---|
| Gender | <0.001 | |||
| Female | 148 (59.7) | 35 (36.8) | 23 (42.6) | |
| Male | 100 (40.3) | 60 (63.2) | 31 (57.4) | |
| Age (years), mean (CI 95%) | 53.9 (52.04–55.93) | 49.5 (46.11–52.92) | 54.8 (50.53–59.24) | 0.044 |
| Nationality | ||||
| Italian | 227 (91.5) | 88 (92.6) | 51 (94.4) | 0.754 |
| Not Italian | 21 (8.5) | 7 (7.4) | 3 (5.6) | |
| Education | 208/248 | 79/95 | 47/54 | |
| None | 1 (0.5) | 0 (-) | 0 (-) | 0.94 |
| Primary School | 13 (6.3) | 6 (7.6) | 3 (6.4) | |
| Middle School | 38 (18.3) | 18 (22.8) | 9 (19.1) | |
| High School | 98 (47.1) | 39 (49.4) | 23 (48.9) | |
| Bachelor’s Degree | 55 (26.4) | 16 (20.3) | 12 (25.5) | |
| Ph.D. | 3 (1.4) | 0 (-) | 0 (-) | |
| Severity of COVID-19 disease, WHO scale [ | ||||
| Asymptomatic | 30 (12.1) | 14 (14.7) | 7 (13.0) | 0.537 |
| Mild disease (without pneumonia) | 162 (65.3) | 65 (68.4) | 34 (63.0) | |
| Moderate disease (pneumonia) | 39 (15.7) | 15 (15.8) | 6 (11.1) | |
| Severe disease (severe pneumonia) | 8 (3.2) | 1 (1.1) | 4 (7.4) | |
| Critical disease, including acute respiratory distress syndrome (ARDS), sepsis and/or septic shock | 7 (2.9) | 0 (-) | 2 (3.7) | |
| Missing | 2 (0.8) | 0 (-) | 1 (1.8) | |
| Hospitalised for COVID-19 | 65 (26.2) | 22 (23.2) | 12 (24.1) | 0.827 |
| In Intensive Care Units | 10 (4.0) | 1 (1.1) | 3 (5.6) | 0.28 |
| Hospitalisation (days), mean (CI 95%) | 9.9 (7.67–12.15) | 7.19 (2.08–12.30) | 12.14 (2.59–21.70) | 0.396 |
| Infected by whom | 0.22 | |||
| I don’t know | 76 (30.6) | 34 (35.8) | 18 (33.3) | |
| Family members | 152 (61.3) | 50 (52.6) | 27 (50) | |
| Colleagues | 16 (6.5) | 10 (10.5) | 6 (11.1) | |
| Family members and Colleagues | 4 (1.6) | 1 (1.1) | 3 (5.6) | |
| COVID-19 symptoms at the onset | ||||
| Yes | 219 (88.3) | 78 (82.1) | 53 (98.1) | 0.014 |
| Symptoms, number, mean (CI 95%) | 4.85 (4.54–5.15) | 4.51(4.03–5.00) | 4.74 (4.01–5.46) | 0.54 |
| Among symptoms, dyspnoea | 73 (29.4) | 26 (27.4) | 15 (27.8) | 0.918 |
| Comorbidities | 137 (55.5) | 46 (48.4) | 24 (44.5) | 0.234 |
| At six months after COVID-19 onset | ||||
| Feeling healed/recovered | ||||
| Yes | 183 (76.3) | 69 (78.4) | 42 (77.8) | 0.908 |
| No | 57 (23.7) | 19 (21.6) | 12 (22.2) | |
| Persisting COVID-19 symptoms | ||||
| Yes | 156 (65.0) | 55 (64.0) | 39 (75.0) | 0.342 |
| No | 84 (35.0) | 31 (36.0) | 13 (25.0) |
Legend: CI, confidence interval; COVID-19, Coronavirus Disease 19; N, number; Ph.D., Doctor of Philosophy; SD, standard deviation; WHO, World Health Organization: asymptomatic; mild disease (without pneumonia); moderate disease (pneumonia); severe disease (severe pneumonia); critical disease, including acute respiratory distress syndrome (ARDS), sepsis, and/or septic shock [27].